Results 131 to 140 of about 1,304 (177)

Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report. [PDF]

Anesth Prog
Kuroda H, Katayama T, Yamaguchi A, Katagiri N, Tsukimoto S, Imaizumi U, Sanuki T.   +6 more
europepmc   +1 more source

Comparison of reversal of rocuronium-induced neuromuscular blockade with sugammadex under remimazolam versus propofol anesthesia: a randomized clinical trial. [PDF]

J Anesth
Kawasaki T, Fujimoto M, Hirata N.
europepmc   +1 more source

What's new in critical illness and injury science? Enhancing anesthetic recovery - Evaluating the role of sugammadex in major abdominal surgeries.

Int J Crit Illn Inj Sci
Sharma SJ.
europepmc   +1 more source

The effects of nondepolarizing neuromuscular blocking agents on endplate currents

, 1981
Durant, N. N., Lambert, J. J., Katz, R. L.   +2 more
core  

Nondepolarizing Neuromuscular Blocking Agents

, 2017
Neuromuscular blocking medications are an important part of the anesthetic management of many patients undergoing surgery. These drugs act at the neuromuscular junction on postsynaptic acetylcholine receptors. Muscle relaxants can be divided into depolarizing and nondepolarizing categories. Succinylcholine is the only depolarizing neuromuscular blocker
Erin Bettendorf, Zhiling Xiong
exaly   +3 more sources

Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids

Muscle and Nerve, 1994
AbstractThe long‐term use of nondepolarizing neuromuscular blocking agents (ND‐NMBA) has recently been implicated as a cause of prolonged muscle weakness, although the site of the lesion and the predisposing factors have been unclear. We report 3 patients (age 37–52 years) with acute respiratory insufficiency who developed prolonged weakness following ...
Richard J Barohn, C E Jackson
exaly   +4 more sources

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Anesthesiology, 2016
Abstract Background Residual postoperative paralysis from nondepolarizing neuromuscular blocking agents (NMBAs) is a known problem. This paralysis has been associated with impaired respiratory function, but the clinical significance remains unclear.
Catherine M Bulka, Jesse M Ehrenfeld, Ehrenfeld Jesse M   +2 more
exaly   +4 more sources

Interaction Between Nondepolarizing Neuromuscular Blocking Agents and Inhalational Anesthetics

Anesthesia & Analgesia, 1989
Although many studies have presented data based on administration of nondepolarizing neuromuscular blocking agents to patients given inhalation anesthesia for 30-45 min, no data exist on the interaction in a clinical situation where the relaxant is administered immediately after the start of anesthesia.
Swen, J, Rashkovsky, O.M, Ket, J.M, Koot, H.W.J, Hermans, J, Agoston, S   +5 more
core   +7 more sources

An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents

Journal of Pharmacokinetics and Pharmacodynamics, 1981
A pharmacodynamic model for nondepolarizing neuromuscular blocking agents (NMBA) is developed and tested with different sets of data (NMBA plasma concentration and time evolution of muscular paralysis). This model takes into account the binding of NMBA to the cholinergic motor endplate receptors and thus permits estimation of the apparent equilibrium ...
Alain D'Hollander, A D'Hollander, C Delcroix   +2 more
exaly   +7 more sources